CVS Health Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
FBR Capital Remains Buyers of CVS Health (CVS) Following 'Solid' Quarter
August 2, 2016 2:16 PM EDTFBR Capital analyst Steven Halper reiterated an Outperform rating and $120 price target on CVS Health (NYSE: CVS) following a 'solid' Q2. The firm remains buyers of the stock.
Halper commented, "On August 2, CVS reported strong 2Q16 results with the PBM segment performing slightly better... More
CVS Health (CVS) Tops Q2 EPS by 2c; Boosts FY16 EPS Outlook
August 2, 2016 6:56 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $1.32, $0.02 better than the analyst estimate of $1.30. Revenue for the quarter came in at $43.7 billion versus the consensus estimate of $44.28 billion.
Same store sales increased 2.1% versus the second quarter of 2015. Pharmacy same store sales rose 3.9% and... More
